← Back to news

Markets

Is EMCOR Group Stock Outperforming the S&P 500?

Y

The Final Trade of 2025: What Wall Street’s Rotation Means for Crypto

Y

Is Camden Property Trust Stock Underperforming the Nasdaq?

Y

Holcim to Buy Peruvian Building-Materials Producer Cementos Pacasmayo

Y

Ford takes $19.5bn EV hit after demand slump

Y

Buy AMD On This Weakness

S

TotalEnergies wins 21-year deal to power Google data centres in Malaysia

Y

Kering Gets $690 Million for Stake in Fifth Avenue Property

Y

Energy Transfer Stock Is Below $17. Time to Buy?

Y

FDVV: Provides Dividend Growth While Benefitting From AI Growth

S

U.S. Treasury Blocks Bid for Lukoil’s Foreign Assets

Y

Is C.H. Robinson Stock Outperforming the Dow?

Y

How Can I Reduce Taxes on My $2,800 Social Security Check?

Y

Constellation Energy: The Market Has Priced In Future Growth, Limiting Near-Term Value

S

Aritzia: Global Demand Waiting To Be Tapped

S

Microsoft: Recent Sell-Off Presents Strong Buying Opportunity

S

UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington’s Data Spurs Mizuho Downgrade and Delayed Launch

Y

Bernstein Affirms Strategy Inc.’s (MSTR) Financial Stability, Sees Evolution into Bitcoin-Focused Operating Business

Y

ORIC Pharmaceuticals (ORIC) Surges as Intriguing ESMO Asia Data for Enozertinib Prompts Wells Fargo to Assign Higher Value

Y

Aurora Innovation, Detmar Logistics Partner to Deploy Autonomous Trucks for 24/7 Frac Sand Hauling in Permian Basin

Y

Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership

Y

Viking Therapeutics (VKTX) Deemed ‘Extremely Attractive’ and Undervalued by Canaccord, Cited as Leader in Obesity Clinical Development

Y

Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS)

Y

Day One Biopharma (DAWN) Announces Positive 3-Year Follow-up Results from Pivotal Phase 2 FIREFLY-1 Trial of OJEMDA (Tovorafenib)

Y

Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027

Y

Wall Street Maintains a Positive Outlook on Datadog, Inc. (DDOG)

Y

Palantir Technologies Inc (PLTR) Announces Renewal of Its 3 Year Contract with DGSI

Y

Barclays Reiterates Buy on Autodesk, Inc. (ADSK), Keeps the PT

Y

Bernstein Reiterates a Buy Rating on Adobe Inc (ADBE)

Y

Snowflake Inc. (SNOW) Down 17.7% Since Q3 2026, Here’s What You Need to Know

Y

ServiceNow (NOW) Up More than 5% Since Veza Acquisition Announcement

Y

Wall Street Maintains its Mixed Outlook on Oracle (ORCL)

Y

Here’s What Jefferies Think About Microsoft Corporation (MSFT)

Y

HSBC Lifts PT on Novartis AG (NVS) to $112 From $106

Y

Barclays Slashes PT on BlackRock (BLK) to $1,340 From $1,360, Maintains an Overweight Rating

Y

JPMorgan Reaffirms Overweight Rating on NextEra Energy (NEE)

Y

Barclays Lifts PT on Blackstone (BX) to $172 From $165

Y

Scotiabank Remains Bullish on Eli Lilly and Company (LLY)

Y

Goldman Sachs Slashes PT on Oracle Corporation (ORCL) to $220 From $320

Y

Evercore ISI Lifts PT on Mastercard Incorporated (MA) to $610 From $600

Y

RBC Capital Reaffirms a Buy Rating on Uber Technologies (UBER)

Y

Evercore ISI Maintains an In Line Rating on Visa Inc. (V), Lifts PT to $380 From $375

Y

China AI chip firm Biren to launch Hong Kong IPO in coming weeks, sources say

Y

CoreWeave’s Staggering Fall From Market Grace Highlights AI Bubble Fears

Y

Iran Hikes Gasoline Prices For The First Time Since 2019

Y

Can U.S. Automakers Compete With Chinese EVs While Focusing on Gas Guzzlers?

Y

Review & Preview: Walking on Eggshells

Y

1 Top Cryptocurrency to Buy Before It Soars Over 1,000%, According to Bernstein

Y

This Dividend ETF Has Crushed the S&P 500 in 2025. Should You Buy It Before 2026?

Y

British regulator kicks off consultation on new crypto rules

Y